Skip Navigation
Contact Us
Search:
Search Toggle
Visit us on Twitter
Visit us on LinkedIn
Toggle Navigation
Search:
Search Submit
About Us
Our Company
Our Team
Management
Board of Directors
Investors
Our Expertise
Pipeline & Science
Our Pipeline
PI3K
Publications
News
Careers
Join Our Team
Job Opportunities
Contact Us
Writing the Next Chapter in
Precision Medicines
for Patients With Cancer
Scroll Down
Writing the Next Chapter in
Precision Medicines
for Patients With Cancer
Discovering and developing the next generation of oncology precision medicines through:
Industry leaders with a proven track record of success
Building a broad pipeline of potentially best-in-class tumor-agnostic therapies
News
July 25, 2024
OnKure Announces the Appointment of Dylan Hartley, Ph.D. as Chief Scientific Officer
June 19, 2024
OnKure Announces the Appointment of Rogan Nunn, J.D., as General Counsel and Secretary
May 13, 2024
Reneo Pharmaceuticals and OnKure Announce Proposed Merger
View All News